Overall Technical outlook

Price Summary

The stock of Concord Biotech Limited experienced a -3.14% plunge, showcasing a lousy market performance.
On 2025-06-12, Concord Biotech Limited's stock began at 2130.4, peaked at 2136.2, declined to 2040.0, and ended the day -3.14% down at 2063.6, with 178500 shares traded.
Over the course of 52 weeks, the stock peaked at 2601.1 and hit a low of 1386.7.
Analysts expect the price of CONCORDBIO to vary between 1700.0 and 2120.0, with an average expected price near 1937.0.

Technicals

Support and Resistance: The price of 2063.6 is supported at 2059.1 and faces resistance at 2210.75. This range suggests key levels for CONCORDBIO where the price may stabilize, with 2059.1 acting as a support and 2210.75 as a cap on gains.
CONCORDBIO supportResistance 352dcc
Support/Resistance for CONCORDBIO


Aroon: The current state of the AROON is neutral for CONCORDBIO, providing no clear indication of a trend in either direction. This suggests that the market may be lacking momentum, making it difficult to predict future movements.
CONCORDBIO aroon 352dcc
Aroon chart for Concord Biotech Limited


Bol. Bands: The BOLL BANDS is in a neutral stance, with no clear direction indicated for the market. This lack of clarity suggests that the market may be in a state of equilibrium for CONCORDBIO, with no strong trend emerging.
CONCORDBIO bbands 352dcc
Bolinger Bands chart for Concord Biotech Limited


Parabolic SAR: The PSAR maintains its bullish stance, setting a significant support level that could help maintain the market's upward movement. This strong support suggests that the market is poised to continue its positive trend, providing confidence in the ongoing bullish momentum.
CONCORDBIO psar 352dcc
Parabolic Stop and Reverse chart for Concord Biotech Limited


Stochastic: The K-line has dipped below the D-line on the stochastic indicator, even as it remains above 80, signaling the potential start of a bearish price move. This setup suggests that the market may be entering a period of weakening momentum, possibly leading to a decline. Investors should monitor the situation for additional bearish signals.
CONCORDBIO stoch 352dcc
Stochastic chart for Concord Biotech Limited


Tripple Moving Agerage: The current reading of the Tripple MOVING AVG indicator suggests a neutral stance, with no clear signals indicating an upward or downward direction. This lack of directional bias suggests the market may be in a period of consolidation or uncertainty.
CONCORDBIO trippleSMA 352dcc
Tripple SMA chart for Concord Biotech Limited


The technical analysis of a company's stock performance is valuable, but only when considered in conjunction with the company's fundamentals. These fundamentals, including financial strength, earnings growth, and leadership, provide a foundation for understanding market movements. Additionally, industry trends and competitive pressures play an important role. By integrating both fundamental and technical analysis, one can better evaluate the company's true potential and make more informed investment decisions.